Press Releases
Imago BioSciences to Participate in the Cowen 42nd Annual Health Care Conference
Feb 28, 2022
Imago BioSciences to Participate in Guggenheim Healthcare Talks 2022 Oncology Conference
Feb 04, 2022
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2021
Dec 12, 2021
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2021
Dec 11, 2021
Imago BioSciences to Host Virtual Investor Event
Dec 01, 2021
Displaying 11 - 15 of 60